Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valeria Carnazzo

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Autoimmunity Reviews|April 15, 2025
The entrenchment of NLRP3 inflammasomes in autoimmune disease-related inflammationValeria Carnazzo, Donato Rigante, Giuliana Restante, et al.
Journal of Endocrinological Investigation|May 4, 2026
Fetuin-A: a potential molecular link between obesity, diabetes (type 2 and type 1) and metabolic steatotic liver disease (MASLD)Ilaria Milani, Gabriele Ciasca, Marianna Chinucci, et al.
Rheumatology (Oxford, England)|August 21, 2023
Calprotectin: two sides of the same coinValeria Carnazzo, Serena Redi, Valerio Basile, et al.
International Journal of Molecular Sciences|May 27, 2026
IgA Subclasses and Free Light Chains in Celiac Disease: A Pilot StudyValeria Carnazzo, Viviana Grieco, Valerio Basile, et al.
International Journal of Molecular Sciences|July 27, 2024
Tumor Necrosis Factor-Alpha: Ally and Enemy in Protean Cutaneous SceneriesKrizia Pocino, Valeria Carnazzo, Annunziata Stefanile, et al.
Journal of Personalized Medicine|September 28, 2023
In Systemic Sclerosis Patients, Peripheral Blood CD21<sup>low</sup> B Cells and Serum IL-4 and IL-21 Influence Joint InvolvementChiara Pellicano, Amalia Colalillo, Valeria Carnazzo, et al.
Clinical and Experimental Medicine|May 22, 2024
Iloprost infusion reduces serological cytokines and hormones of hypoxia and inflammation in systemic sclerosis patientsChiara Pellicano, Amalia Colalillo, Oriana De Marco, et al.
Journal of Personalized Medicine|August 29, 2024
New Biomarkers in Liver Fibrosis: A Pass through the Quicksand?Marzia Tagliaferro, Mariapaola Marino, Valerio Basile, et al.
Expert Review of Clinical Immunology|October 11, 2025
Anti-angiotensin 2 receptor 1 antibody (anti-AT1R) and anti-endothelin receptor type a (anti-ETAR) as biomarkers of endothelial dysfunction in systemic sclerosis (SSc) patientsChiara Pellicano, Annalisa Villa, Gabriella Cusa, et al.
International Journal of Molecular Sciences|December 9, 2023
NLRP3 Inflammasome Involvement in Heart, Liver, and Lung Diseases-A Lesson from Cytokine Storm SyndromeCecilia Napodano, Valeria Carnazzo, Valerio Basile, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Autoimmunity Reviews|April 15, 2025
The entrenchment of NLRP3 inflammasomes in autoimmune disease-related inflammationValeria Carnazzo, Donato Rigante, Giuliana Restante, et al.
Journal of Endocrinological Investigation|May 4, 2026
Fetuin-A: a potential molecular link between obesity, diabetes (type 2 and type 1) and metabolic steatotic liver disease (MASLD)Ilaria Milani, Gabriele Ciasca, Marianna Chinucci, et al.
Rheumatology (Oxford, England)|August 21, 2023
Calprotectin: two sides of the same coinValeria Carnazzo, Serena Redi, Valerio Basile, et al.
International Journal of Molecular Sciences|May 27, 2026
IgA Subclasses and Free Light Chains in Celiac Disease: A Pilot StudyValeria Carnazzo, Viviana Grieco, Valerio Basile, et al.
International Journal of Molecular Sciences|July 27, 2024
Tumor Necrosis Factor-Alpha: Ally and Enemy in Protean Cutaneous SceneriesKrizia Pocino, Valeria Carnazzo, Annunziata Stefanile, et al.
Journal of Personalized Medicine|September 28, 2023
In Systemic Sclerosis Patients, Peripheral Blood CD21<sup>low</sup> B Cells and Serum IL-4 and IL-21 Influence Joint InvolvementChiara Pellicano, Amalia Colalillo, Valeria Carnazzo, et al.
Clinical and Experimental Medicine|May 22, 2024
Iloprost infusion reduces serological cytokines and hormones of hypoxia and inflammation in systemic sclerosis patientsChiara Pellicano, Amalia Colalillo, Oriana De Marco, et al.
Journal of Personalized Medicine|August 29, 2024
New Biomarkers in Liver Fibrosis: A Pass through the Quicksand?Marzia Tagliaferro, Mariapaola Marino, Valerio Basile, et al.
Expert Review of Clinical Immunology|October 11, 2025
Anti-angiotensin 2 receptor 1 antibody (anti-AT1R) and anti-endothelin receptor type a (anti-ETAR) as biomarkers of endothelial dysfunction in systemic sclerosis (SSc) patientsChiara Pellicano, Annalisa Villa, Gabriella Cusa, et al.
International Journal of Molecular Sciences|December 9, 2023
NLRP3 Inflammasome Involvement in Heart, Liver, and Lung Diseases-A Lesson from Cytokine Storm SyndromeCecilia Napodano, Valeria Carnazzo, Valerio Basile, et al.
Pageof 3